Cypherpunk Technologies (NASDAQ:CYPH) Issues Quarterly Earnings Results

Cypherpunk Technologies (NASDAQ:CYPH) announced its quarterly earnings data on Wednesday. The company reported $0.18 EPS for the quarter, FiscalAI reports.

Cypherpunk Technologies Stock Performance

NASDAQ CYPH traded down $0.02 on Friday, hitting $0.63. The stock had a trading volume of 115,855 shares, compared to its average volume of 3,262,079. The firm has a 50-day moving average of $0.68 and a 200-day moving average of $0.78. Cypherpunk Technologies has a 52-week low of $0.25 and a 52-week high of $3.70. The company has a market capitalization of $67.36 million, a price-to-earnings ratio of 1.13 and a beta of 0.09.

Analyst Ratings Changes

A number of equities research analysts have commented on CYPH shares. Wall Street Zen raised Cypherpunk Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, July 4th. Weiss Ratings lowered shares of Cypherpunk Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, July 31st. Finally, Cantor Fitzgerald raised Cypherpunk Technologies to a “strong-buy” rating in a report on Friday, July 3rd. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $0.90.

Hedge Funds Weigh In On Cypherpunk Technologies

Several institutional investors have recently modified their holdings of the company. Simplify Asset Management Inc. bought a new position in shares of Cypherpunk Technologies in the 4th quarter worth approximately $2,172,000. Acadian Asset Management LLC boosted its stake in Cypherpunk Technologies by 470.4% during the first quarter. Acadian Asset Management LLC now owns 1,280,531 shares of the company’s stock worth $389,000 after acquiring an additional 1,056,047 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in Cypherpunk Technologies in the first quarter worth about $576,000. Geode Capital Management LLC bought a new position in shares of Cypherpunk Technologies during the fourth quarter valued at approximately $615,000. Finally, State Street Corp bought a new stake in shares of Cypherpunk Technologies in the 4th quarter worth approximately $163,000. 30.46% of the stock is currently owned by institutional investors.

Cypherpunk Technologies Company Profile

Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.

DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.